Transdermal Delivery Solutions and MHC Medical Products Announce License for Penetran Plus® Topical Pain Reliever

Title

Transdermal Delivery Solutions and MHC Medical Products Announce License for Penetran Plus® Topical Pain Reliever

Authors
Publish Date

Business Wire: July 5, 2016 – PALM BEACH GARDENS, FL, U.S.A. – Transdermal Delivery Solutions Corporation (TDSC), www.TDSC.us, announced today the signing of a product license arrangement with MHC Medical Products, LLC of Cincinnati, Ohio.

“We are pleased to announce the finalization of our agreement for this first product with the team at MHC,” said Kenneth Kirby, president of TDSC. “MHC is the manufacturer of one of the country’s fastest growing lines of branded medical devices and other consumer healthcare products, including the EasyTouch® brand of insulin syringes and blood glucose meters, HealthPro® blood glucose meters, and SureLife® blood pressure monitors.” With the acquisition of Penetran Plus® , MHC is expanding into the over-the-counter pain relief market.

Up until this time, Penetran Plus had limited regional distribution. “We are pleased and honored to have the MHC team acquire the product license and expand the distribution,” said Kirby. Penetran Plus is a topical analgesic gel that is marketed as an over-the-counter remedy for temporary relief of minor aches and pains, bruises, and strains. The product was designed with a pleasant natural lemon oil fragrance, a nonsticky formula, and has been successfully tested for pains associated with arthritis in a double-blind study against placebo, which was published in a peer-reviewed journal. The product label has been reviewed by the FDA Center for Drug Evaluation and Research Office of Unapproved Drugs and Labeling Compliance (OUDLC), Over the Counter Branch, and found to be in compliance with the OTC Monograph for Topical Pain Relief.
 

TDSC is committed to advancing the science of transdermal drug delivery using its patented spray-on delivery system. TDSC’s proprietary system enables medications to be delivered directly through the skin, for systemic or localized application, utilizing its rapid-acting, patchless, spray-on technology. The company’s technology is flexible enough to be applicable to a very wide range of compounds up to small peptides for pharmaceutical or cosmetic use. No other company can offer similar, consumer friendly, dosingflexible solutions. www.youtube.com/watch?v=Ff-1z1SYoF8.